Philip Martin Arlen

Dr. Philip Martin Arlen, M.D. is a medical oncology expert witness from Maryland. He also has expertise in internal medicine. He has active medical licenses from the states of Maryland, Georgia and Florida. He is also certified by the American Board of Internal Medicine. He completed his Bachelor of Arts in 1986 from the Emory University at Atlanta, Georgia and then earned his Doctor of Medicine in 1991 from the Medical College of Georgia, School of Medicine at Augusta, Georgia. He further pursued his internship in Internal Medicine and his residency in Internal Medicine from the Georgia Baptist Medical Center located at Atlanta, Georgia. He further pursued his fellowship in Hematology and Oncology from the Emory University. He also pursued his second fellowship in Biotechnology from the Laboratory of Tumor Immunology and Biology, Division of Basic Sciences at the National Cancer Institute at Bethesda, Maryland. Currently, Dr. Arlen is the President and Chief Executive Officer of the Precision Biologics. He is also the Attending Physician in medical oncology at the Walter Reed National Naval Medical Center and the National Cancer Institute. Formerly, Dr. Arlen served as the President and Chief Executive Officer of the Neogenix Oncology, Inc. Dr. Arlen was the Principal Investigator and Associate Investigator on numerous clinical trials involving the use of cancer vaccines and other immunostimulatory molecules.  He has numerous publications to his credit.